2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

W E E Eberhardt; D De Ruysscher; W Weder; C Le Péchoux; P De Leyn; H Hoffmann; V Westeel; R Stahel; E Felip; S Peters; Rolf Stahel; Enriqueta Felip; Solange Peters; Keith Kerr; Benjamin Besse; Johan Vansteenkiste; Wilfried Eberhardt; Martin Edelman; Tony Mok; Ken O'Byrne; Silvia Novello; Lukas Bubendorf; Antonio Marchetti; Paul Baas; Martin Reck; Konstantinos Syrigos; Luis Paz-Ares; Egbert F Smit; Peter Meldgaard; Alex Adjei; Marianne Nicolson; Lucio Crinó; Paul Van Schil; Suresh Senan; Corinne Faivre-Finn; Gaetano Rocco; Giulia Veronesi; Jean-Yves Douillard; Eric Lim; Christophe Dooms; Walter Weder; Dirk De Ruysscher; Cecile Le Pechoux; Paul De Leyn; Virginie Westeel

doi:10.1093/annonc/mdv187

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

W E E Eberhardt, D De Ruysscher, W Weder, C Le Péchoux, P De Leyn, H Hoffmann, V Westeel, R Stahel, E Felip, S Peters, Rolf Stahel (Collaborator), Enriqueta Felip (Collaborator), Solange Peters (Collaborator), Keith Kerr (Collaborator), Benjamin Besse (Collaborator), Johan Vansteenkiste (Collaborator), Wilfried Eberhardt (Collaborator), Martin Edelman (Collaborator), Tony Mok (Collaborator), Ken O'Byrne (Collaborator)Silvia Novello (Collaborator), Lukas Bubendorf (Collaborator), Antonio Marchetti (Collaborator), Paul Baas (Collaborator), Martin Reck (Collaborator), Konstantinos Syrigos (Collaborator), Luis Paz-Ares (Collaborator), Egbert F Smit (Collaborator), Peter Meldgaard (Collaborator), Alex Adjei (Collaborator), Marianne Nicolson (Collaborator), Lucio Crinó (Collaborator), Paul Van Schil (Collaborator), Suresh Senan (Collaborator), Corinne Faivre-Finn (Collaborator), Gaetano Rocco (Collaborator), Giulia Veronesi (Collaborator), Jean-Yves Douillard (Collaborator), Eric Lim (Collaborator), Christophe Dooms (Collaborator), Walter Weder (Collaborator), Dirk De Ruysscher (Collaborator), Cecile Le Pechoux (Collaborator), Paul De Leyn (Collaborator), Virginie Westeel (Collaborator)

Research output: Contribution to journal › Article › peer-review

Abstract

To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.

Original language	English
Journal	Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Volume	26
Issue number	8
DOIs	https://doi.org/10.1093/annonc/mdv187
Publication status	Published - Aug 2015

Keywords

ESMO
locally advanced
non-small-cell lung cancer
recommendations
stage III

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdv187

Cite this

Eberhardt, W. E. E., De Ruysscher, D., Weder, W., Le Péchoux, C., De Leyn, P., Hoffmann, H., Westeel, V., Stahel, R., Felip, E., Peters, S., Stahel, R., Felip, E., Peters, S., Kerr, K., Besse, B., Vansteenkiste, J., Eberhardt, W., Edelman, M., Mok, T., ... Westeel, V. (2015). 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 26(8). https://doi.org/10.1093/annonc/mdv187

@article{03405338fdbc433eb7544b4383e25f18,

title = "2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.",

abstract = "To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.",

keywords = "ESMO, locally advanced, non-small-cell lung cancer, recommendations, stage III",

author = "Eberhardt, {W E E} and {De Ruysscher}, D and W Weder and {Le P{\'e}choux}, C and {De Leyn}, P and H Hoffmann and V Westeel and R Stahel and E Felip and S Peters and Rolf Stahel and Enriqueta Felip and Solange Peters and Keith Kerr and Benjamin Besse and Johan Vansteenkiste and Wilfried Eberhardt and Martin Edelman and Tony Mok and Ken O'Byrne and Silvia Novello and Lukas Bubendorf and Antonio Marchetti and Paul Baas and Martin Reck and Konstantinos Syrigos and Luis Paz-Ares and Smit, {Egbert F} and Peter Meldgaard and Alex Adjei and Marianne Nicolson and Lucio Crin{\'o} and {Van Schil}, Paul and Suresh Senan and Corinne Faivre-Finn and Gaetano Rocco and Giulia Veronesi and Jean-Yves Douillard and Eric Lim and Christophe Dooms and Walter Weder and {De Ruysscher}, Dirk and {Le Pechoux}, Cecile and {De Leyn}, Paul and Virginie Westeel",

year = "2015",

month = aug,

doi = "10.1093/annonc/mdv187",

language = "English",

volume = "26",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology / ESMO",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "8",

}

Eberhardt, WEE, De Ruysscher, D, Weder, W, Le Péchoux, C, De Leyn, P, Hoffmann, H, Westeel, V, Stahel, R, Felip, E, Peters, S, Stahel, R, Felip, E, Peters, S, Kerr, K, Besse, B, Vansteenkiste, J, Eberhardt, W, Edelman, M, Mok, T, O'Byrne, K, Novello, S, Bubendorf, L, Marchetti, A, Baas, P, Reck, M, Syrigos, K, Paz-Ares, L, Smit, EF, Meldgaard, P, Adjei, A, Nicolson, M, Crinó, L, Van Schil, P, Senan, S, Faivre-Finn, C, Rocco, G, Veronesi, G, Douillard, J-Y, Lim, E, Dooms, C, Weder, W, De Ruysscher, D, Le Pechoux, C, De Leyn, P & Westeel, V 2015, '2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.', Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 26, no. 8. https://doi.org/10.1093/annonc/mdv187

TY - JOUR

T1 - 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

AU - Eberhardt, W E E

AU - De Ruysscher, D

AU - Weder, W

AU - Le Péchoux, C

AU - De Leyn, P

AU - Hoffmann, H

AU - Westeel, V

AU - Stahel, R

AU - Felip, E

AU - Peters, S

A2 - Stahel, Rolf

A2 - Felip, Enriqueta

A2 - Peters, Solange

A2 - Kerr, Keith

A2 - Besse, Benjamin

A2 - Vansteenkiste, Johan

A2 - Eberhardt, Wilfried

A2 - Edelman, Martin

A2 - Mok, Tony

A2 - O'Byrne, Ken

A2 - Novello, Silvia

A2 - Bubendorf, Lukas

A2 - Marchetti, Antonio

A2 - Baas, Paul

A2 - Reck, Martin

A2 - Syrigos, Konstantinos

A2 - Paz-Ares, Luis

A2 - Smit, Egbert F

A2 - Meldgaard, Peter

A2 - Adjei, Alex

A2 - Nicolson, Marianne

A2 - Crinó, Lucio

A2 - Van Schil, Paul

A2 - Senan, Suresh

A2 - Faivre-Finn, Corinne

A2 - Rocco, Gaetano

A2 - Veronesi, Giulia

A2 - Douillard, Jean-Yves

A2 - Lim, Eric

A2 - Dooms, Christophe

A2 - Weder, Walter

A2 - De Ruysscher, Dirk

A2 - Le Pechoux, Cecile

A2 - De Leyn, Paul

A2 - Westeel, Virginie

PY - 2015/8

Y1 - 2015/8

N2 - To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.

AB - To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.

KW - ESMO

KW - locally advanced

KW - non-small-cell lung cancer

KW - recommendations

KW - stage III

U2 - 10.1093/annonc/mdv187

DO - 10.1093/annonc/mdv187

M3 - Article

C2 - 25897013

SN - 0923-7534

VL - 26

JO - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

JF - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

IS - 8

ER -

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this